Related references
Note: Only part of the references are listed.Epidemiological characteristics of ovarian cancer in Korea
Boyoung Park et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2010)
Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
K. Huhtinen et al.
BRITISH JOURNAL OF CANCER (2009)
A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2009)
Effects of personal characteristics on serum CA125, mesothelin, and HE4 levels in healthy postmenopausal women at high-risk for ovarian cancer
Kimberly A. Lowe et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence
Laura J. Havrilesky et al.
GYNECOLOGIC ONCOLOGY (2008)
The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
Richard G. Moore et al.
GYNECOLOGIC ONCOLOGY (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
WFDC2 (HE4): A potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung
Lynne Bingle et al.
RESPIRATORY RESEARCH (2006)
Bead-based ELISA for validation of ovarian cancer early detection markers
N Scholler et al.
CLINICAL CANCER RESEARCH (2006)
Proteins with whey-aicidic-protein motifs and cancer
D Bouchard et al.
LANCET ONCOLOGY (2006)
Potential markers that complement expression of CA125 in epithelial ovarian cancer
DG Rosen et al.
GYNECOLOGIC ONCOLOGY (2005)
Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometriold ovarian carcinomas
R Drapkin et al.
CANCER RESEARCH (2005)
Transcriptional targeting in ovarian cancer cells using the human epididymis protein 4 promoter
NB Berry et al.
GYNECOLOGIC ONCOLOGY (2004)
The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms
L Bingle et al.
ONCOGENE (2002)
Share Paper
